Up­dat­ed: FDA ex­plains why it won't pull Jaz­z's ac­cel­er­at­ed ap­proval de­spite a failed con­fir­ma­to­ry tri­al

When does a failed con­fir­ma­to­ry tri­al eval­u­at­ing over­all sur­vival not amount to a re­quest from FDA to pull an ac­cel­er­at­ed ap­proval for a can­cer drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.